If you thought the placebo effect was all in the mind, think again.
A placebo is traditionally
defined as a harmless pill, medicine, or procedure prescribed more for
the psychological benefit to the patient than for any physiological
effect or in research, a substance that has no therapeutic effect, used
as a control in testing new drugs.
For most of us, the potency of
sugar pills is synonymous with the power of positive thinking; it works
because you believe you’re taking a real drug. But new research
continues to rattle this assumption and peel away further layers to the
inner workings and potential therapeutic applications of the ‘powerful
placebo’.
Most recently, researchers at
Harvard Medical School’s Osher Research Center and Beth Israel Deaconess
Medical Center (BIDMC) found that placebos work even when administered
without 'deception'.
It is broadly understood that to
prescribe a placebo openly as an actual treatment would risk
undermining the effect. But data on placebos are so compelling that
Harvard associate professor of medicine Ted Kaptchuk teamed up with
colleagues at BIDMC to explore whether or not the power of placebos can
be harnessed honestly and respectfully.
To do this, 80 patients
suffering from irritable bowel syndrome (IBS) were divided into two
groups: one group, the controls, received no treatment, while the other
group received a regimen of placebos – honestly described as 'like sugar
pills' – which they were instructed to take twice daily.
“Not only did we make it
absolutely clear that these pills had no active ingredient and were made
from inert substances, but we actually had ‘placebo’ printed on the
bottle,” says Prof Kaptchuk. “We told the patients that they didn't have
to even believe in the placebo effect. Just take the pills.”
For a three-week period, the
patients were monitored. By the end of the trial, nearly twice as many
patients treated with the placebo reported adequate symptom relief as
compared to the control group (59% versus 35%).
Also, on other outcome measures,
patients taking the placebo doubled their rates of improvement to a
degree roughly equivalent to the effects of the most powerful IBS
medications.
This particular aspect of their
discovery has been mirrored in other studies and is proving quietly
disconcerting for pharmaceutical companies who pour billions into
developing lucrative new drugs only to find that, on occasion, the
placebo group in their clinical trials fared just as well or even better
than the active arm.
For a range of ailments, from pain and nausea to depression and Parkinson’s disease, placebos – whether sugar pills, saline
injections, or sham surgery – have often produced results that rival
those of standard therapies.
But, of course, there are limits
to even the strongest placebo effect. No simulation could set a broken
arm or clear a blocked artery. It can ease the discomfort of
chemotherapy, but it won’t stop the growth of tumours.
For the most part, placebos appear to affect symptoms rather than underlying diseases, although sometimes, as in the case of depression or irritable bowel syndrome, there’s no meaningful distinction between the two.
For more than a decade,
scientists have made tremendous strides in demonstrating the biological
truth of the placebo effect. Numerous studies have shown that these
inert pills can trigger verifiable changes in the body. The enduring
search now is to uncover the precise mechanisms that elicit
placebo-related effects, and to understand how these can be reliably
harnessed.
Advances in image processing are aiding investigators in this quest. A study, published in Science
in 2009, utilised functional magnetic resonance imaging (MRI) to scan
the spinal cords of 15 healthy volunteers, homing in on an area called
the dorsal horn, which transmits pain signals coming up through the
spinal cord into the pain-related areas in the brain.
During the scan, the volunteers
received laser 'pinpricks' to their hands. The volunteers were told that
a pain-relief cream had been applied to one of their hands and a
'control' placebo cream to the other. But unknown to the volunteers, an
identical 'inactive' control cream was administered to both hands.
When people believed that they
had received the active cream, they reported feeling 25% less
pain and showed significantly reduced activity in the spinal cord
pathway that processes pain.
Previously, it has been shown
that placebo causes the release of natural opioids in areas of the brain
involved in pain control.
“We’ve shown that psychological
factors can influence pain at the earliest stage of the central nervous
system, in a similar way to drugs like morphine,” said Falk Eippert, of
the University Medical Centre Hamburg-Eppendorf, who led the study.
A world authority in this field,
Fabrizio Benedetti, professor of clinical and applied physiology at the
University of Turin Medical School, has devoted more than 15 years to
mapping many of the neurobiological mechanisms of the placebo effect,
uncovering a broad range of the body’s self-healing responses.
He says that placebo-activated opioids, for example, not only relieve pain, they also modulate heart
rate and respiration. The neurotransmitter dopamine, when triggered by
placebo treatment, helps improve motor function in Parkinson's patients.
Mechanisms like these can elevate mood, sharpen cognitive ability,
alleviate digestive disorders, relieve insomnia, and limit the secretion
of stress-related hormones like insulin and cortisol.
Impressed by such findings, some
researchers and clinicians hope to import them somehow from bench to
bedside – adding placebo, in a structured way, to the doctor’s medical
repertoire. But any attempt to harness the placebo effect immediately
runs into problems. To present a dummy pill as real medicine would be,
by most standards, to lie.
And yet, research has shown that
many doctors incorporate the placebo into their therapeutic arsenal.
For example, a 2004 study in the British Medical Journal found
that 60% of doctors in Israel used placebos in their medical
practice, most commonly to ‘fend off’ requests for unjustified
medications or to calm a patient.
So if the medical profession see
little harm in prescribing placebos, should they should be more widely
available to the general public? After all, they are the ideal medicine:
placebos typically have no side effects, are essentially free, and have
clinical research to back up their beneficial effects.
Actually, a variety of placebo
cures are available on the internet. One of the most popular is Obecalp,
natural cherry-flavoured chewable tablets for children. Launched in
2008, Obecalp claims to be the first standardised, branded and
pharmaceutical grade placebo on the market. Its name is ‘placebo’
spelled backwards.
The idea is a seductive one – to
harness the placebo effect to comfort children who are a little unwell,
without risking side-effects. They are designed for when 'children need
a little more than a kiss to make it go away'.
However, Obecalp has received
mixed reactions from the medical profession. One issue is that the pills
will be used without medical supervision, creating a small risk that
parents may delay bringing children with a serious illness to their GP
because symptoms are masked for a while by the placebo effect.
Dr Clare Gerada, vice-chair of
the Royal College of General Practitioners, described the pill as
'medicalising love'. Douglas Kamerow, associate editor of the British Medical Journal,
highlighted a more serious threat. He pointed out in his editorial that
by giving children a tablet for every ailment, parents may encourage
them to think that popping a pill is the be-all and end-all of health.
“Sure, there are kids who end
up wanting a colourful plaster for every ache and injury, but I have
never seen an adult addicted to plasters. I have seen many adults who
want a pill for every ill.”
But perhaps the real source of
the placebo’s effect is the medical care that goes along with it, that
the practice of medicine and the trappings of medical care is providing
tangible healing influences.
For example, a study published in the British Medical Journal
in 2008 described experiments conducted on patients with irritable
bowel syndrome. Two groups underwent sham acupuncture, while a third
remained on a waiting list. The patients receiving the sham treatment
were divided into two subgroups – the first was treated in a friendly,
empathetic way and the second group had their care delivered in a
businesslike fashion.
None of the three groups had received ‘real’ treatment, yet investigators reported sharply different results.
After three weeks, 28% of
patients on the waiting list reported 'adequate relief,' compared with
44% in the group treated impersonally, and fully 62% in the group with
caring doctors. This last figure is comparable to rates of improvement
from a drug now commonly taken for the illness, without the drug’s
potentially severe side-effects.
The lead investigator was
Harvard Medical School’s Prof Ted Kaptchuk. In this research, and his
2010 IBS study mentioned earlier, he emphasised that, rather than mere
positive thinking contributing to the placebo effect, there may be
significant benefit to the actual performance of the medical treatment
ritual.
If this is true, then the
takeaway message is not necessarily that doctors should be prescribing
more fake pills but that as much thought should go into the medication
selected as to the context in which it’s given.
Prof Anne Harrington |
The definition of placebo effect
has now broadened beyond dosing with inert pills to include questions
about whether healing is still in part an ‘art’, and issues such as how
the relationship between doctors and patients affects treatment
outcomes.
At its best, that doctor-patient
ritual activates positive expectations, triggers associations with past
healing experiences, and eases distress in ways that can alleviate
suffering.
Prof Anne Harrington, professor of the history of science at Harvard University and author of the book The Placebo Effect: An Interdisciplinary Exploration, suggests that a better way to think about the placebo effect would be as “the sum total of effects”.
Part of that experience might be
going into a waiting room where the patient sees lots of certificates
on the wall, and where a confident doctor walks in with a white coat
that designates him as a professional expert. “All of these things
produce the placebo effect,” she says.
Perhaps the secret of the
placebo is rooted in the patient-doctor relationship. It may be about
how people respond to symbols and about the intangible parts of
medicine, such as the inherent capacity of human beings for
self-healing.